Synopsis
0
EU WC
0
KDMF
0
VMF
0
Europe
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kewpie Corporation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Emulsifying Agents
Topical
Coating Systems & Additives
Solubilizers
Controlled & Modified Release
Fillers, Diluents & Binders
Film Formers & Plasticizers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
85
PharmaCompass offers a list of Glycine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glycine manufacturer or Glycine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glycine manufacturer or Glycine supplier.
PharmaCompass also assists you with knowing the Glycine API Price utilized in the formulation of products. Glycine API Price is not always fixed or binding as the Glycine Price is obtained through a variety of data sources. The Glycine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Corilin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Corilin, including repackagers and relabelers. The FDA regulates Corilin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Corilin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Corilin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Corilin supplier is an individual or a company that provides Corilin active pharmaceutical ingredient (API) or Corilin finished formulations upon request. The Corilin suppliers may include Corilin API manufacturers, exporters, distributors and traders.
click here to find a list of Corilin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Corilin DMF (Drug Master File) is a document detailing the whole manufacturing process of Corilin active pharmaceutical ingredient (API) in detail. Different forms of Corilin DMFs exist exist since differing nations have different regulations, such as Corilin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Corilin DMF submitted to regulatory agencies in the US is known as a USDMF. Corilin USDMF includes data on Corilin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Corilin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Corilin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Corilin Drug Master File in Japan (Corilin JDMF) empowers Corilin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Corilin JDMF during the approval evaluation for pharmaceutical products. At the time of Corilin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Corilin suppliers with JDMF on PharmaCompass.
A Corilin CEP of the European Pharmacopoeia monograph is often referred to as a Corilin Certificate of Suitability (COS). The purpose of a Corilin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Corilin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Corilin to their clients by showing that a Corilin CEP has been issued for it. The manufacturer submits a Corilin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Corilin CEP holder for the record. Additionally, the data presented in the Corilin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Corilin DMF.
A Corilin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Corilin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Corilin suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Corilin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Corilin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Corilin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Corilin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Corilin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Corilin suppliers with NDC on PharmaCompass.
Corilin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Corilin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Corilin GMP manufacturer or Corilin GMP API supplier for your needs.
A Corilin CoA (Certificate of Analysis) is a formal document that attests to Corilin's compliance with Corilin specifications and serves as a tool for batch-level quality control.
Corilin CoA mostly includes findings from lab analyses of a specific batch. For each Corilin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Corilin may be tested according to a variety of international standards, such as European Pharmacopoeia (Corilin EP), Corilin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Corilin USP).
